These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22213804)

  • 21. Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.
    Lauer GM; Lucas M; Timm J; Ouchi K; Kim AY; Day CL; Schulze Zur Wiesch J; Paranhos-Baccala G; Sheridan I; Casson DR; Reiser M; Gandhi RT; Li B; Allen TM; Chung RT; Klenerman P; Walker BD
    J Virol; 2005 Oct; 79(20):12979-88. PubMed ID: 16189000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell recognition of hepatitis B and C viral antigens.
    Jung MC; Diepolder HM; Pape GR
    Eur J Clin Invest; 1994 Oct; 24(10):641-50. PubMed ID: 7531642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes.
    Schulze zur Wiesch J; Lauer GM; Day CL; Kim AY; Ouchi K; Duncan JE; Wurcel AG; Timm J; Jones AM; Mothe B; Allen TM; McGovern B; Lewis-Ximenez L; Sidney J; Sette A; Chung RT; Walker BD
    J Immunol; 2005 Sep; 175(6):3603-13. PubMed ID: 16148104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing Hepatitis C Virus-Specific CD4
    Hartnell F; Esposito I; Swadling L; Brown A; Phetsouphanh C; de Lara C; Gentile C; Turner B; Dorrell L; Capone S; Folgori A; Barnes E; Klenerman P
    Hepatology; 2020 Nov; 72(5):1541-1555. PubMed ID: 32012325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
    Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
    Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.
    Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher A; Hampartzoumian T; Zekry A; Lloyd AR
    J Immunol Methods; 2012 Jan; 375(1-2):148-58. PubMed ID: 22019644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.
    Nascimbeni M; Mizukoshi E; Bosmann M; Major ME; Mihalik K; Rice CM; Feinstone SM; Rehermann B
    J Virol; 2003 Apr; 77(8):4781-93. PubMed ID: 12663785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-alpha treatment induces delayed CD4 proliferative responses to the hepatitis C virus nonstructural protein 3 regardless of the outcome of therapy.
    Zhang ZX; Milich DR; Peterson DL; Birkett A; Schvarcz R; Weiland O; Sällberg M
    J Infect Dis; 1997 Jun; 175(6):1294-301. PubMed ID: 9180166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
    Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
    Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
    Godkin A; Jeanguet N; Thursz M; Openshaw P; Thomas H
    Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response.
    Meyer MF; Lehmann M; Cornberg M; Wiegand J; Manns MP; Klade C; Wedemeyer H
    Virol J; 2007 Jun; 4():58. PubMed ID: 17562015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.
    Gerlach JT; Diepolder HM; Jung MC; Gruener NH; Schraut WW; Zachoval R; Hoffmann R; Schirren CA; Santantonio T; Pape GR
    Gastroenterology; 1999 Oct; 117(4):933-41. PubMed ID: 10500077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance.
    Folgori A; Spada E; Pezzanera M; Ruggeri L; Mele A; Garbuglia AR; Perrone MP; Del Porto P; Piccolella E; Cortese R; Nicosia A; Vitelli A;
    Gut; 2006 Jul; 55(7):1012-9. PubMed ID: 16484505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
    BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus.
    Bailey JR; Dowd KA; Snider AE; Osburn WO; Mehta SH; Kirk GD; Thomas DL; Ray SC
    J Infect Dis; 2015 Sep; 212(6):914-23. PubMed ID: 25754978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.
    Harris RA; Sugimoto K; Kaplan DE; Ikeda F; Kamoun M; Chang KM
    Hepatology; 2008 Jul; 48(1):70-9. PubMed ID: 18537178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
    Pilli M; Zerbini A; Penna A; Orlandini A; Lukasiewicz E; Pawlotsky JM; Zeuzem S; Schalm SW; von Wagner M; Germanidis G; Lurie Y; Esteban JI; Haagmans BL; Hezode C; Lagging M; Negro F; Homburger Y; Neumann AU; Ferrari C; Missale G;
    Gastroenterology; 2007 Oct; 133(4):1132-43. PubMed ID: 17919489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
    Hartlage AS; Walker CM; Kapoor A
    J Virol; 2020 May; 94(10):. PubMed ID: 32102885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+ T cell responses in hepatitis C virus infection.
    Semmo N; Klenerman P
    World J Gastroenterol; 2007 Sep; 13(36):4831-8. PubMed ID: 17828814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.